Click for best price

Respiratory Syncytial Virus Vaccines Market Size, Share 2022

Market Analysis and Insights: Global Respiratory Syncytial Virus Vaccines Market

The global Respiratory Syncytial Virus Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Syncytial Virus Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Syncytial Virus Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Syncytial Virus Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Syncytial Virus Vaccines market.

Global Respiratory Syncytial Virus Vaccines Scope and Market Size

Respiratory Syncytial Virus Vaccines market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Palivizumab

RSVpreF PF06928316

RSVPreF3 OA (GSK3844766A)

mRNA-1345

Janssen RSV Vaccine

ResVax

Nirsevimab (MEDI8897)

MVA-BN RSV

Segment by Application

Hospital

Clinic

Research Institute

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Pfizer Inc.Pfizer Inc.

Sanofi

Merck Sharp & Dohme

GlaxoSmithKline

SOBI

Johnson & Johnson

Bavarian Nordic

Novavax

AstraZeneca

Moderna

Codagenix

Intravacc

Alphavax

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Respiratory Syncytial Virus Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Respiratory Syncytial Virus Vaccines, with price, sales, revenue, and global market share of Respiratory Syncytial Virus Vaccines from 2019 to 2022.

Chapter 3, the Respiratory Syncytial Virus Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Respiratory Syncytial Virus Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Respiratory Syncytial Virus Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Respiratory Syncytial Virus Vaccines.

Chapter 13, 14, and 15, to describe Respiratory Syncytial Virus Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Respiratory Syncytial Virus Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Respiratory Syncytial Virus Vaccines Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	85 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Palivizumab
1.2.3 RSVpreF PF06928316
1.2.4 RSVPreF3 OA (GSK3844766A)
1.2.5 mRNA-1345
1.2.6 Janssen RSV Vaccine
1.2.7 ResVax
1.2.8 Nirsevimab (MEDI8897)
1.2.9 MVA-BN RSV
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Vaccines Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Vaccines Market Perspective (2017-2028)
2.2 Respiratory Syncytial Virus Vaccines Growth Trends by Region
2.2.1 Respiratory Syncytial Virus Vaccines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Syncytial Virus Vaccines Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Syncytial Virus Vaccines Market Dynamics
2.3.1 Respiratory Syncytial Virus Vaccines Industry Trends
2.3.2 Respiratory Syncytial Virus Vaccines Market Drivers
2.3.3 Respiratory Syncytial Virus Vaccines Market Challenges
2.3.4 Respiratory Syncytial Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue (2017-2022)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Vaccines Revenue
3.4 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Vaccines Revenue in 2021
3.5 Respiratory Syncytial Virus Vaccines Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Vaccines Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Vaccines Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2023-2028)
5 Respiratory Syncytial Virus Vaccines Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
6.2 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
6.3 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
8.3 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
9.2 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
9.3 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
10.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Detail
11.1.2 Pfizer Inc.Pfizer Inc. Business Overview
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Introduction
11.1.4 Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.1.5 Pfizer Inc.Pfizer Inc. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Introduction
11.2.4 Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Detail
11.3.2 Merck Sharp & Dohme Business Overview
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Introduction
11.3.4 Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.3.5 Merck Sharp & Dohme Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Introduction
11.4.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 SOBI
11.5.1 SOBI Company Detail
11.5.2 SOBI Business Overview
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Introduction
11.5.4 SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.5.5 SOBI Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Introduction
11.6.4 Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Detail
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Introduction
11.7.4 Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.7.5 Bavarian Nordic Recent Development
11.8 Novavax
11.8.1 Novavax Company Detail
11.8.2 Novavax Business Overview
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Introduction
11.8.4 Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.8.5 Novavax Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Introduction
11.9.4 AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.9.5 AstraZeneca Recent Development
11.10 Moderna
11.10.1 Moderna Company Detail
11.10.2 Moderna Business Overview
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Introduction
11.10.4 Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.10.5 Moderna Recent Development
11.11 Codagenix
11.11.1 Codagenix Company Detail
11.11.2 Codagenix Business Overview
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Introduction
11.11.4 Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.11.5 Codagenix Recent Development
11.12 Intravacc
11.12.1 Intravacc Company Detail
11.12.2 Intravacc Business Overview
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Introduction
11.12.4 Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.12.5 Intravacc Recent Development
11.13 Alphavax
11.13.1 Alphavax Company Detail
11.13.2 Alphavax Business Overview
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Introduction
11.13.4 Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.13.5 Alphavax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Palivizumab
Table 3. Key Players of RSVpreF PF06928316
Table 4. Key Players of RSVPreF3 OA (GSK3844766A)
Table 5. Key Players of mRNA-1345
Table 6. Key Players of Janssen RSV Vaccine
Table 7. Key Players of ResVax
Table 8. Key Players of Nirsevimab (MEDI8897)
Table 9. Key Players of MVA-BN RSV
Table 10. Global Respiratory Syncytial Virus Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2017-2022)
Table 14. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2023-2028)
Table 16. Respiratory Syncytial Virus Vaccines Market Trends
Table 17. Respiratory Syncytial Virus Vaccines Market Drivers
Table 18. Respiratory Syncytial Virus Vaccines Market Challenges
Table 19. Respiratory Syncytial Virus Vaccines Market Restraints
Table 20. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Respiratory Syncytial Virus Vaccines Market Share by Players (2017-2022)
Table 22. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2021)
Table 23. Ranking of Global Top Respiratory Syncytial Virus Vaccines Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Vaccines Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Respiratory Syncytial Virus Vaccines Product Solution and Service
Table 27. Date of Enter into Respiratory Syncytial Virus Vaccines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2017-2022)
Table 31. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2023-2028)
Table 33. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2017-2022)
Table 35. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2023-2028)
Table 37. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 41. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 42. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2023-2028) & (US$ Million)
Table 43. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 44. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 47. Pfizer Inc.Pfizer Inc. Company Detail
Table 48. Pfizer Inc.Pfizer Inc. Business Overview
Table 49. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product
Table 50. Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 51. Pfizer Inc.Pfizer Inc. Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Respiratory Syncytial Virus Vaccines Product
Table 55. Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Merck Sharp & Dohme Company Detail
Table 58. Merck Sharp & Dohme Business Overview
Table 59. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product
Table 60. Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 61. Merck Sharp & Dohme Recent Development
Table 62. GlaxoSmithKline Company Detail
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product
Table 65. GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. SOBI Company Detail
Table 68. SOBI Business Overview
Table 69. SOBI Respiratory Syncytial Virus Vaccines Product
Table 70. SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 71. SOBI Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product
Table 75. Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Bavarian Nordic Company Detail
Table 78. Bavarian Nordic Business Overview
Table 79. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product
Table 80. Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 81. Bavarian Nordic Recent Development
Table 82. Novavax Company Detail
Table 83. Novavax Business Overview
Table 84. Novavax Respiratory Syncytial Virus Vaccines Product
Table 85. Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 86. Novavax Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Respiratory Syncytial Virus Vaccines Product
Table 90. AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Moderna Company Detail
Table 93. Moderna Business Overview
Table 94. Moderna Respiratory Syncytial Virus Vaccines Product
Table 95. Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 96. Moderna Recent Development
Table 97. Codagenix Company Detail
Table 98. Codagenix Business Overview
Table 99. Codagenix Respiratory Syncytial Virus VaccinesProduct
Table 100. Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 101. Codagenix Recent Development
Table 102. Intravacc Company Detail
Table 103. Intravacc Business Overview
Table 104. Intravacc Respiratory Syncytial Virus VaccinesProduct
Table 105. Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 106. Intravacc Recent Development
Table 107. Alphavax Company Detail
Table 108. Alphavax Business Overview
Table 109. Alphavax Respiratory Syncytial Virus VaccinesProduct
Table 110. Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 111. Alphavax Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus Vaccines Market Share by Type: 2021 VS 2028
Figure 2. Palivizumab Features
Figure 3. RSVpreF PF06928316 Features
Figure 4. RSVPreF3 OA (GSK3844766A) Features
Figure 5. mRNA-1345 Features
Figure 6. Janssen RSV Vaccine Features
Figure 7. ResVax Features
Figure 8. Nirsevimab (MEDI8897) Features
Figure 9. MVA-BN RSV Features
Figure 10. Global Respiratory Syncytial Virus Vaccines Market Share by Application in 2021 & 2028
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Research Institute Case Studies
Figure 14. Respiratory Syncytial Virus Vaccines Report Years Considered
Figure 15. Global Respiratory Syncytial Virus Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Respiratory Syncytial Virus Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Respiratory Syncytial Virus Vaccines Market Share by Region: 2021 VS 2028
Figure 18. Global Respiratory Syncytial Virus Vaccines Market Share by Players in 2021
Figure 19. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Vaccines Revenue in 2021
Figure 21. North America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 23. United States Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 27. Germany Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Share by Region (2017-2028)
Figure 35. China Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 43. Mexico Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 47. Turkey Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Pfizer Inc.Pfizer Inc. Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 50. Sanofi Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 51. Merck Sharp & Dohme Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 53. SOBI Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 55. Bavarian Nordic Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 56. Novavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 58. Moderna Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 59. Codagenix Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 60. Intravacc Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 61. Alphavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Respiratory Syncytial Virus Vaccines Market Research Report 2022